Register for free to
view the full innovation profile.
A novel peptide hormone has been identified as a potential marker for Alzheimer's disease, Type 2 Diabetes mellitus and Creutzfeldt-Jakob disease. A UK patent has been granted.
About
User friendly measurement of novel markers in saliva will help in both diagnosis and therapeutic monitoring of disease. I have identified a novel marker that is found in saliva and has also been shown to be present in the Alzheimer's brain. A UK patent has been granted for the use of this marker in both therapeutic and diagnostic settings
Key Benefits
The identified marker can be measured in saliva samples and as such this will allow the development of non-invasive diagnostic and therapeutic monitoring medical technologies.
Applications
The technology can be applied to both the diagnostic and pharmaceutical industries.